Looking for space?
Login

What is happening at Pivot Park?

News

Find out what’s happening at Pivot Park. Stay informed on the latest collaborations, scientific breakthroughs and developments in drug discovery and life sciences. Explore how innovators at the park are shaping the future of health, technology and entrepreneurship.

Grizzly building
News

Press release: Reaching big heights at Pivot Park

The new Grizzly building has reached it’s highest point at Pivot Park this week. Grizzly provides space for offices and laboratories. This space is much needed, because successful start-ups and scale-ups are outgrowing their space. With the arrival of Grizzly, Pivot Park stimulates innovation and employment. Companies will have the space and facilities to develop further. This allows them to excel further and to continue to play a leading role worldwide in the field in which they operate.

Read More »
16 February 2023
Oncolines logo 2022
News

Symeres acquires Oncolines, further strengthening its drug discovery and biology capabilities

Symeres, a leading global drug discovery Contract Research Organization (CRO) and Contract Development and Manufacturing Organization (CDMO), announces the acquisition of Oncolines, a Netherlands-based CRO that provides early biology services and cell-line profiling assays. Oncolines is Symeres’ third acquisition in the past ten months, and will take group revenues to over €100m.

Read More »
16 January 2023
Arno website
News

10 years Pivot Park: Pivot Park

Pivot Park has become an essential location for biopharmaceutical innovation and drug discovery in Europe. The latest addition to Pivot Park is an eight-floor multitenant office and lab space, and the shell of the next building is already up. This additional accommodation is a testament to the steady, continuous growth of Pivot Park.

Read More »
16 January 2023
Nelisca
News

10 years Pivot Park: Nelisca

“It was a revelation for me. As Accountants, we usually look back at the end of every year. But to work with partners in Life Science we needed a change of mind set. We wanted to collaborate and facilitate more, to help our clients achieve their goals. We think along with our clients and help them build healthy, growing companies.”

Read More »
5 January 2023
Wordpress news 6
News

10 years Pivot Park: 3D-PharmXchange

François van Och, one of the three managing partners, explains: “By offering independent strategic project management, you are a credible advocate for clients and their projects. This creates synergy between the disciplines and intensive collaboration with the parties we work for. And that’s important for an effective time and cost-efficient process.”

Read More »
19 December 2022
Wordpress news 5
News

10 years Pivot Park: Innatoss

Innatoss is a diagnostic laboratory specialising in infectious diseases such as Lyme disease, Q fever and since 2020, COVID-19. Innatoss is pushing the boundaries of diagnostics by making innovative use of existing tests. If no such tests exist then Innatoss will develop them. The laboratory regularly supports and assists leading organisations in addressing infectious diseases in the work place.

Read More »
8 December 2022
Surviving the Dutch participants with their certificate
News

Surviving the Dutch graduation

Yesterday a group of international community members finished the second edition of the ‘Surviving the Dutch Program’ at Pivot Park. For 10 weeks they have taken Dutch lessons followed by either Dutch culture training or group activities.

Read More »
8 December 2022
Wordpress news 4
News

10 years Pivot Park: BioConnection

BioConnection’s operational expertise is filling vials and syringes for small to medium-sized pharmaceutical companies and Bio-techs. In 17 years since it was founded, this Contract Development and Manufacturing Organisation (CDMO) has grown into a major company with a global customer base.

Read More »
5 December 2022
Wordpress news 3
News

10 years Pivot Park: Oncolines

“Oncolines is a subsidiary of the Netherlands Translational Research Center (NTRC), the company I started in 2012 with my MSD/Organon colleague Rogier Buijsman,” says Zaman. “From 2012 to 2021, NTRC worked on new technologies to help develop novel drug candidates. These include a cancer cell line panel and bioinformatics analysis tools. We used these technologies to support our in-house drug discovery but also to provide services for clients. Over the years, NTRC has developed so fast that we decided to separate the precision medicine services and to expand it further as Oncolines.”

Read More »
28 November 2022

Erwin Wurm | Am I a House?

For the first time, the artist shows a cross-section of his work, from Narrow Furniture to One Minute Sculptures, within the walls of a historic building. Villa Constance, a former home that today houses Museum Jan Cunen, is not only a location but also part of the conversation. Because what exactly is a house?
Read more (NL)

#100YEARSPHARMAFUTURE

The development of medicines in Oss began one hundred years ago. It was then that the foundations were laid for what would become a flourishing pharmaceutical sector in the Netherlands, leading to groundbreaking discoveries such as insulin and the anti-conception pill.

Today, the entire chain is still represented in Oss, from early-stage research to the commercial scale production of medicines. Working in Oss, we focus on the health of people all over the world. Employees at dozens of companies large and small put their heart and soul into new medicines, products and services that will improve lives worldwide. Together, our strength lies in our combination of broad knowledge about the development of medicines and a thorough understanding of the requirements of high-quality production.

This shared past and common values stimulate strong bonds among everyone who works in pharmaceuticals in Oss. We build on qualities, expertise and networks that go back decades. And with a wide variety of pharmaceutical companies, suppliers and scientific institutions all located nearby, we offer an attractive business climate and an excellent basis for international collaboration.

We are proud to work together to create a better and healthier future for all, a collaboration that in turn fuels growing employment: today, most pharmaceutical jobs in the Netherlands are in Oss. Here we connect talent and companies and stimulate entrepreneurship, while our expert employees are our most important asset. Their drive ensures that Oss has an influence on health all over the world.

Pharma in Oss offers endless opportunities to startups and talent in a city and region that is a joy to live and work in. We are committed to collaboration and sustainable and successful entrepreneurship. Oss’s pharmaceutical companies are intrinsically competitive while also being committed to quality and safety. This, plus their focus on new health solutions and contemporary technology, makes us a leader in our pursuit of a better life for people worldwide.